Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study
Go back to Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 3.57 +0.30 (9.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.27 | 52 Week High | $9.58 | |||
| Open | $3.40 | 52 Week Low | $2.34 | |||
| Day High | $3.69 | P/E | N/A | |||
| Day Low | $3.20 | EPS | $-0.34 | |||
| Volume | 1,985,336 | |||||

